Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2,061.88 million between 2022 and 2027; Growth driven by increasing approval of therapeutics – Technavio

NEW YORK, March 10, 2023 /PRNewswire/ — The diffuse large B-cell lymphoma (DLBCL) therapeutics market size is forecast to grow by USD 2,061.88 million between 2022 and 2027, and the growth momentum will accelerate at a CAGR of 7.96% during the forecast period. The number of regulatory…

Leave a Reply

Your email address will not be published. Required fields are marked *